PULSTA TPV Observational Study

NCT07747207 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-08-10

No results posted yet for this study

Summary

The purpose of the study is to determine the long-term follow-up clinical outcomes, effectiveness, and safety data of the PULSTA Transcatheter Pulmonary Valve (TPV) implantation in a real-world situation

Conditions

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY
  • Taewoong Medical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Mario Carminati · Niguarda Hospital

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2028-07-31
Completion
2033-10-31

Countries

  • Germany
  • Italy
  • Poland
  • South Korea
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07747207 on ClinicalTrials.gov